Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
Fundación de investigación HM
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seattle Children's Hospital
Nationwide Children's Hospital
Nationwide Children's Hospital
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
University of Florida
National Cancer Institute (NCI)
Hoffmann-La Roche
University of Florida